Heron Therapeutics (HRTX) 8-K Update
Date of Event: November 4, 2025
Heron Therapeutics filed an 8-K reporting the issuance of its Earnings Press Release covering financial results for the three and nine months ended September 30, 2025.
- Item Reported: Item 2.02 (Results of Operations and Financial Condition).
- Key Action: The company provided notification that Q3 2025 results are available.
- Investor Note: The specific financial metrics, revenue, and EPS figures are located within Exhibit 99.1. This filing serves only as the formal announcement.
- **Fil